MP-4

N/A

Report date: 2022/11/25 17:58:03
NME

Base Information

Drug NameMP-4
Drug Alias NameApogen (multiple sclerosis)Apogen MSMP-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsWounds and InjuriesHypoxiaShock, Traumatic +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[20] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute of Health, Islamabad
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSangart Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesHypoxiaShock, Traumatic +[10] 

Other Information

ATC CodeN/A
Related LinksN/A